Cytosorbents Corporation

NASDAQ:CTSO

0.84 (USD) • At close December 23, 2024
Bedrijfsnaam Cytosorbents Corporation
Symbool CTSO
Munteenheid USD
Prijs 0.838
Beurswaarde 45,969,556
Dividendpercentage 0%
52-weken bereik 0.7 - 1.82
Industrie Medical Devices
Sector Healthcare
CEO Dr. Phillip P. Chan M.D., Ph.D.
Website https://www.cytosorbents.com

An error occurred while fetching data.

Over Cytosorbents Corporation

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications,

Vergelijkbare Aandelen

Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc.

LUCD

0.775 USD

Tabula Rasa HealthCare, Inc. logo

Tabula Rasa HealthCare, Inc.

TRHC

10.5 USD

Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

XLO

1.11 USD

Adverum Biotechnologies, Inc. logo

Adverum Biotechnologies, Inc.

ADVM

4.74 USD

Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc.

CAPR

14.13 USD

Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

ALZN

1.15 USD

HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Inc.

HOOK

2.03 USD

Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc.

PBYI

2.81 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)